Collin Smyser Net Worth

The estimated Net Worth of Collin Smyser is at least $1.37 Million dollars as of 19 May 2024. Collin Smyser owns over 812 units of Option Care Health stock worth over $1,365,952 and over the last 2 years Collin sold OPCH stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Collin Smyser OPCH stock SEC Form 4 insiders trading

Collin has made over 3 trades of the Option Care Health stock since 2023, according to the Form 4 filled with the SEC. Most recently Collin exercised 812 units of OPCH stock worth $26,333 on 19 May 2024.

The largest trade Collin's ever made was buying 2,500 units of Option Care Health stock on 14 August 2023 worth over $86,725. On average, Collin trades about 589 units every 52 days since 2022. As of 19 May 2024 Collin still owns at least 42,120 units of Option Care Health stock.

You can see the complete history of Collin Smyser stock trades at the bottom of the page.

What's Collin Smyser's mailing address?

Collin's mailing address filed with the SEC is C/O OPTION CARE HEALTH, INC., 3000 LAKESIDE DRIVE, SUITE 300N, BANNOCKBURN, IL, 60015.

Insiders trading at Option Care Health

Over the last 5 years, insiders at Option Care Health have traded over $6,426,460,535 worth of Option Care Health stock and bought 202,320 units worth $5,246,552 . The most active insiders traders include Timothy P Sullivan, Elizabeth Quadros Betten, and Dearborn Partners Llcmadiso.... On average, Option Care Health executives and independent directors trade stock every 28 days with the average trade being worth of $157,254,886. The most recent stock trade was executed by R Carter Pate on 3 September 2024, trading 1,465 units of OPCH stock currently worth $47,422.

What does Option Care Health do?

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; infusion therapies for bleeding disorders; therapies that women need to survive and thrive through high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.

Complete history of Collin Smyser stock trades at Option Care Health

Option Care Health executives and stock owners

Option Care Health executives and other stock owners filed with the SEC include:

• Harriet Booker,
  Chief Operating Officer
• Harriet Booker,
  Chief Operating Officer
• Rich Denness,
  Chief Strategy Officer
• John Rademacher,
  Chief Executive Officer, Director
• John C. Rademacher,
  CEO, Pres & Director
• Michael Shapiro,
  Chief Financial Officer
• Michael H. Shapiro,
  CFO & Sr. VP
• R. Carter Pate,
  Independent Director
• Clifford Berman,
  General Counsel
• Richard P. Denness,
  Chief Commercial Officer
• Clifford E. Berman,
  Sr. VP, Gen. Counsel & Corp. Sec.
• Harry Jansen Kraemer,
  Independent Non-Executive Chairman of the Board
• David Golding,
  Independent Director
• John Arlotta,
  Independent Director
• Nitin Sahney,
  Independent Director
• Timothy Sullivan,
  Director
• Elizabeth Betten,
  Director
• Mark Vainisi,
  Director
• Alan Nielsen,
  Director
• Christopher Hartman,
  Chief Growth Officer
• Luke Whitworth,
  Sr. VP of Revenue Cycle Management
• Julie Koenig,
  Sr. VP of Operations
• Christopher Frederick Hartman,
  Chief Growth Officer
• Matthew Deans,
  Sr. VP of Bus. Devel.
• Michael W. Rude,
  Sr. VP & Chief HR Officer
• Cari Reed,
  Sr. VP & Chief Compliance Officer
• Brett Michalak,
  Chief Information Officer
• Robert R. Kampstra,
  Sr. VP of Fin. & Chief Accounting Officer
• Femi Adewunmi,
  Chief Medical Officer
• Barbara W. Bodem,
  Director
• Norman L. Wright,
  Director
• Boots Alliance, Inc.Och Us ...,
  
• Dearborn Partners Llcmadiso...,
  
• Dearborn Capital Partners V...,
  
• Elizabeth D Bierbower,
  Director
• Collin Smyser,
  GC & Corporate Secretary
• Natasha Deckmann,
  Director
• Seema Kumbhat,
  Chief Medical Officer
• Dearborn Partners Llcmadiso...,
  
• Robert R Kampstra,
  CHIEF ACCOUNTING OFFICER
• Dearborn Partners Llcmadiso...,
  
• Luke Whitworth,
  Chief Operating Officer
• Michael Bavaro,
  Chief Human Resources Officer
• Christopher L. Grashoff,
  Chief Growth Officer
• Eric Brandt,
  Director